236 related articles for article (PubMed ID: 30028958)
1. Mechanistic Insights into Colorectal Cancer Phenomics from Fundamental and Organotypic Model Studies.
Campbell FC; Loughrey MB; McClements J; Deevi RK; Javadi A; Rainey L
Am J Pathol; 2018 Sep; 188(9):1936-1948. PubMed ID: 30028958
[TBL] [Abstract][Full Text] [Related]
2. Fundamental control of grade-specific colorectal cancer morphology by Src regulation of ezrin-centrosome engagement.
Rainey L; Deevi RK; McClements J; Khawaja H; Watson CJ; Roudier M; Van Schaeybroeck S; Campbell FC
J Pathol; 2020 Jul; 251(3):310-322. PubMed ID: 32315081
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C zeta suppresses low- or high-grade colorectal cancer (CRC) phenotypes by interphase centrosome anchoring.
Deevi RK; Javadi A; McClements J; Vohhodina J; Savage K; Loughrey MB; Evergren E; Campbell FC
J Pathol; 2018 Apr; 244(4):445-459. PubMed ID: 29520890
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype.
Deevi RK; McClements J; McCloskey KD; Fatehullah A; Tkocz D; Javadi A; Higginson R; Marsh Durban V; Jansen M; Clarke A; Loughrey MB; Campbell FC
Oncotarget; 2016 Aug; 7(31):49042-49064. PubMed ID: 27119498
[TBL] [Abstract][Full Text] [Related]
5. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
Front Immunol; 2020; 11():614300. PubMed ID: 33643296
[TBL] [Abstract][Full Text] [Related]
6. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
Schlicker A; Beran G; Chresta CM; McWalter G; Pritchard A; Weston S; Runswick S; Davenport S; Heathcote K; Castro DA; Orphanides G; French T; Wessels LF
BMC Med Genomics; 2012 Dec; 5():66. PubMed ID: 23272949
[TBL] [Abstract][Full Text] [Related]
7. Untangling the complexities of micropapillary cancer
Charles Campbell F
J Pathol; 2021 Dec; 255(4):343-345. PubMed ID: 34564856
[TBL] [Abstract][Full Text] [Related]
8. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
[TBL] [Abstract][Full Text] [Related]
9. PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system.
Jagan IC; Deevi RK; Fatehullah A; Topley R; Eves J; Stevenson M; Loughrey M; Arthur K; Campbell FC
Neoplasia; 2013 Nov; 15(11):1218-30. PubMed ID: 24348097
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
11. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
Jesinghaus M; Schmitt M; Lang C; Reiser M; Scheiter A; Konukiewitz B; Steiger K; Silva M; Tschurtschenthaler M; Lange S; Foersch S; Becker KF; Saur D; Friess H; Halfter K; Engel J; Boxberg M; Pfarr N; Wilhelm D; Weichert W
Am J Surg Pathol; 2021 Jul; 45(7):969-978. PubMed ID: 34105518
[TBL] [Abstract][Full Text] [Related]
12. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
[TBL] [Abstract][Full Text] [Related]
14. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
15. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
16. Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
Khaliq AM; Erdogan C; Kurt Z; Turgut SS; Grunvald MW; Rand T; Khare S; Borgia JA; Hayden DM; Pappas SG; Govekar HR; Kam AE; Reiser J; Turaga K; Radovich M; Zang Y; Qiu Y; Liu Y; Fishel ML; Turk A; Gupta V; Al-Sabti R; Subramanian J; Kuzel TM; Sadanandam A; Waldron L; Hussain A; Saleem M; El-Rayes B; Salahudeen AA; Masood A
Genome Biol; 2022 May; 23(1):113. PubMed ID: 35538548
[TBL] [Abstract][Full Text] [Related]
17. Histological grading in colorectal cancer: new insights and perspectives.
Barresi V; Reggiani Bonetti L; Ieni A; Caruso RA; Tuccari G
Histol Histopathol; 2015 Sep; 30(9):1059-67. PubMed ID: 26004398
[TBL] [Abstract][Full Text] [Related]
18. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
Dienstmann R; Salazar R; Tabernero J
Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
20. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
